I am a
Home I AM A Search Login

Papers of the Week

Papers: 9 Jul 2022 - 15 Jul 2022

Pharmacology/Drug Development

2022 Jul 11

Neurol Sci

Ditans: a new prospective for the therapy of migraine attack?


Viticchi G, Falsetti L, Silvestrini M, Bartolini M
Neurol Sci. 2022 Jul 11.
PMID: 35816257.


Migraine attack is characterized by disabling pain and associated symptoms. Triptans represent the "gold standard" therapy, but cardiac subjects have significant limitations for this approach. New drug families are under consideration to expand therapeutic offerings, especially in the presence of contraindications or for non-responsive patients. This review aimed to analyze studies related to the category of "ditans," with a focus on lasmiditan, which is available for human use.